India To Get Most Of The 40-50 Million Doses Of Covid-19 Vaccine Stockpiled By Serum Institute
Serum Institute of India (Pic Via Twitter)
Pune-based Serum Institute of India (SII), the world s largest vaccine maker in terms of doses, has stockpiled around 40-50 million doses of its Covid-19 vaccine candidate, Covishield, reports
Economic Times.
According to the report, India will initially get most of the vaccine shots stockpiled by the company as the exports of the Covishield would require the World Health Organisation s (WHO) pre-qualification, which is likely to take around a month after regulatory approval.
SII s CEO Adar Poonawalla has said that the company expects to receive the emergency use approval from the Drug Controller General of India (DCGI) for the vaccine in the next few days. He said that the stockpiled doses of Covishield are being augmented every week.
Bharat Biotech to make presentation before expert panel for vaccine approval
By IANS |
Published on
Wed, Dec 30 2020 17:27 IST |
0 Views
Bharat Biotech to make presentation before expert panel for vaccine approval. Image Source: IANS News
New Delhi, Dec 30 : Hyderabad-based Bharat Biotech will make a presentation before the Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) on Wednesday evening for approval of its vaccine - Covaxin, government sources told IANS.
Earlier on Wednesday, the Serum Institute of India (SII) s application for emergency use authorisation of its Covid-19 vaccine was also considered by the Subject Expert Committee.
The development came hours after the United Kingdom accepted the recommendation of the Medicines and Healthcare Regulatory Agency (MHRA) to authorise the Oxford University-AstraZeneca s Covid-19 vaccine, Covishield, for emergency approval use.
The Nepal government has written to the Indian government, requesting for procurement of Covid-19 vaccine to inoculate around 20 per cent of the Nepali population. The Indian government is procuring the jabs manufactured in its own country to vaccinate its people against Covid-19. The Ministry of Foreign Affairs recently wrote to the Indian government, requesting for the supply of the vaccines that would suffice the need for the 20 per cent of the population. Last week, Nepali Ambassador to India, Nilamber Acharya also held meeting with senior officials of Pune-based Serum Institute of India (SII), the largest vaccine manufacturer in the world that is also producing Covid vaccine developed by Oxford University.
Indian regulator seeks more time as UK authorises Oxford COVID-19 jab; six things about cheap, easy to store vaccine In India, a decision on emergency usage of the vaccine, which is being manufactured by Pune-based Serum Institute of India, is likely to come next year with the Subject Expert Committee (SEC) on COVID-19 seeking more time today FP Staff December 30, 2020 22:48:25 IST Representational image.
British regulator granted emergency usage authorisation to the easy to store and cheap AstraZeneca/Oxford vaccine on Wednesday.
Though the Indian authorities on Wednesday sought more time to decide on the emergency authorisation of the vaccine, which is manufactured in India as Covishield by Pune-based Serum Institute of India in a tie-up with AstraZeneca, the UK s authorisation has given a shot in the arm to the global fight against coronavirus
Bharat Biotech to make presentation before expert panel for COVID-19 vaccine approval mid-day.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mid-day.com Daily Mail and Mail on Sunday newspapers.